Pharmacy Technology

NEW YORK That connection between healthy foods and pharmacy is the most powerful card a supermarket pharmacy retailer can play in the battle for prescription-drug marketshare.

NEW YORK This is target marketing at its finest; not only are Hispanics more likely to embrace homeopathy, but baby care as a category resonates extremely well among Hispanics. And in it’s a format that will appeal to today’s new mothers — multi-cultural women who have embraced the Internet.

According to a Pew Hispanic Center report, 78% of Latinos who are English-dominant and 76% of bilingual Latinos use the Internet, compared with 32% of Spanish-dominant Hispanic adults.

NEW YORK The findings of the Take Care Health Systems’ survey are important as they undoubtedly underscore the importance of worksite clinics, which are growing increasingly common as U.S. employers look for ways to curb skyrocketing healthcare costs and bolster employee health and productivity.

NEW YORK This battle was supposed to be over by now.

NEW YORK News that Take Care Health Systems now offers treatment for skin conditions and minor injuries is further evidence that the retail-based clinic model continues to evolve and implement valuable services to augment patients’ healthcare needs.

If you could be a superhero for one day, what special powers do you think you would choose for yourself? Would it be the power of flight? How about invisibility? Or invincibility?

What if I told you none of that gets you anywhere in Washington? If you really want to be a hero in Washington, you need a set of super powers that on the surface might seem pretty ordinary, like the power of utter visibility, the power of seamless communication or the power to persuade and convince.

NEW YORK Support for a regulatory pathway for biosimilars has grown rapidly, and even a few branded companies, such as Merck & Co. and Pfizer, have expressed interest. But Rep. Henry Waxman's, D-Calif., request that the Obama administration look for legal means to let the FDA approve biosimilars before his bill, its companion in the Senate or fellow California Democratic Rep. Anna Eshoo’s competing bill is put to a vote, is a strong signal that biogenerics are going to be a reality in American health care — and sooner rather than later.

NEW YORK Making sure that medication therapy management is a part of any new healthcare reform legislation is a major priority for this industry, but it may be even more critical to the U.S. healthcare system.